Regeneration and tolerance factor (RTF), a novel membrane protein, has also been introduced as a new attractive target for immunotherapy, since its overexpression has been observed in many kinds of malignant and metastatic cancers, and it has been shown to exert immunoregulatory properties13,14. This evidence concerns the gene ATP6V0A2 and metastatic malignant neoplasm.